Company · CIK 0001714798
Prevail Therapeutics Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/APrevail Therapeutics Inc.0001104659-21-024244 · 73.1 KBSEC(opens sec.gov)
- SC 13G/APrevail Therapeutics Inc.0001104659-21-024136 · 159.8 KBSEC(opens sec.gov)
- SC 13G/APrevail Therapeutics Inc.0001193125-21-041576 · 48.1 KBSEC(opens sec.gov)
- SC 13G/APrevail Therapeutics Inc.0000935836-21-000106 · 46.8 KBSEC(opens sec.gov)
- SC 13GPrevail Therapeutics Inc.0001123292-21-000143 · 206.7 KBSEC(opens sec.gov)
- SC 13D/APrevail Therapeutics Inc.0000947871-21-000118 · 76.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-014276 · 112.0 KBSEC(opens sec.gov)
- SC TO-T/APrevail Therapeutics Inc.0001193125-21-014250 · 88.0 KBSEC(opens sec.gov)
- SC 13DPrevail Therapeutics Inc.0001193125-20-323947 · 93.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-317624 · 789.8 KBSEC(opens sec.gov)
Insiders
- Abeliovich AsaDirector, President & CEO
- Adams Timothy MDirector
- Carson William H.Director
- Dai YongChief Technology Officer
- ELI LILLY & Co10% Owner
- GORDON CARL LDirector, 10% Owner
- Hefti FranzChief Development Officer
- Kaplan BrettChief Financial Officer
- Minkow EmilyChief Business Officer
- Nader FrancoisDirector
Tickers
No tickers on record.
Addresses
business
430 EAST 29TH STREET, SUITE 940
NEW YORK, NY, 10016
mailing
430 EAST 29TH STREET, SUITE 940
NEW YORK, NY, 10016
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies